WHO Issues Alert Over Contaminated Oral Liquid Medicines from India
The World Health Organization (WHO) has issued a Medical Product Alert following the identification of three substandard (contaminated) oral liquid medicines in India.
Safety | 14/10/2025 | By Dineshwori | 203
Aarti Drugs to Halt Chlorosulfonation Process at Tarapur Unit After Gas Leak
The Maharashtra Pollution Control Board (MPCB) has directed Aarti Drugs to voluntarily close down chlorosulfonation process at the PTSCL section of its T-150 unit in Tarapur as a precautionary and safety measure, following a gas leakage incident.
Safety | 10/09/2025 | By Dineshwori | 150
Dr Reddy's UK API Facility Receives Seven FDA Observations Following Inspection
Dr Reddy’s Laboratories has announced that its Active Pharmaceutical Ingredient (API) manufacturing facility in Mirfield, West Yorkshire, United Kingdom, has come under scrutiny from the United States Food and Drug Administration (FDA).
Safety | 08/09/2025 | By Darshana | 210
ASPA Calls for Unified, Multi-Stakeholder Approach to Combat Counterfeiting
Through evidence-based research, collaboration, and the adoption of authentication technologies, we can build a future where counterfeiting is no longer a silent threat, says Puneet Maithani, Director – Industry Affairs, ASPA.
Safety | 05/08/2025 | By Dineshwori | 214
Monitor NDMA Impurity in Ranitidine Formulation: DCGI Directs Indian Drugmakers
The DCGI has instructed drug controllers of all States and Union Territories to ensure that manufacturers under their jurisdiction monitor the presence of N-Nitrosodimethylamine(NDMA) - a potentially carcinogenic impurity – in the active pharmaceutical ingredient (API) and formulation of the antacid Ranitidine.
Safety | 31/07/2025 | By Dineshwori | 394
Sarepta Pauses Shipments of Duchenne Gene Therapy Elevidys Amid FDA Safety Review
Sarepta Therapeutics has announced a voluntary and temporary suspension of all US shipments of its Duchenne muscular dystrophy (DMD) gene therapy, ELEVIDYS (delandistrogene moxeparvovec), following the FDA’s distribution suspension request last week.
Safety | 24/07/2025 | By Dineshwori | 257
Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing
Custom Portable Sampling Isolator Improves Safety of Pharmaceutical Manufacturing
Safety | 18/08/2023 | By Sudeep Soparkar | 937
Safety | 23/01/2023 | By Sudeep Soparkar | 859
Safety | 03/01/2023 | By Sudeep Soparkar | 1145
Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations
Freudenberg Medical has accomplished ISO 14001 confirmation for every one of the 11 locales in the United States, Costa Rica, Germany, Ireland, and China. Meaning, all Freudenberg Medical activities overall satisfy the most noteworthy guidelines for ecological administration.
Safety | 13/04/2022 | By Sudeep Soparkar | 1121
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy